Literature DB >> 1782102

Phospholipid changes in the bones of the hypophosphatemic mouse.

A L Boskey1, H Gilder, E Neufeld, B Ecarot, F H Glorieux.   

Abstract

The mineral and lipid composition of the bones of 35 day old hypophosphatemic (Hyp/Y) and control (+/Y) mice were compared in order to test the hypothesis that phosphate status has an effect on the complexed acidic phospholipid content of developing bones. The Hyp/Y bones were found to be rachitic and osteomalacic, having significantly reduced mineral content. That mineral was shown by X-ray diffraction to consist of larger/more perfect crystals than that in +/Y animals, indicating either a preference for crystal growth rather than new mineral deposition, or an increased mineral turnover. The increased crystal perfection was confirmed by chemical analyses which showed an increased calcium to phosphorus ratio in the Hyp/Y bones. The bones of Hyp/Y animals had significantly reduced complexed acidic phospholipid contents relative to those of control animals. Since these complexes are believed to play a role in vitro and in vivo mineral deposition, it is suggested that the deficiency of these complexes contributes to the mineralization defect. The magnitude of the complexed acidic phospholipid deficiency in the Hyp/Y animals indicates the importance of phosphate for the formation of these lipids. Although the proportion of phosphatidylserine and phosphatidylinositol and lysophospholipids tended to be reduced in the Hyp/Y bones, the absence of other statistically significant phospholipid abnormalities in the bones and brains of these animals suggests that the lipid defect is not systemic, but is associated with a decrease in phosphate at the site of bone formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782102     DOI: 10.1016/8756-3282(91)90021-a

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  5 in total

1.  Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice.

Authors:  B Zhang; Y Sun; L Chen; C Guan; L Guo; C Qin
Journal:  Oral Dis       Date:  2010-03-09       Impact factor: 3.511

Review 2.  Bone quality changes associated with aging and disease: a review.

Authors:  Adele L Boskey; Laurianne Imbert
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

3.  The kidney sodium-phosphate co-transporter alters bone quality in an age and gender specific manner.

Authors:  Adele L Boskey; Lyudmilla Lukashova; Lyudmila Spevak; Yan Ma; Saeed R Khan
Journal:  Bone       Date:  2013-01-17       Impact factor: 4.398

4.  Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.

Authors:  Elizabeth Miller; Demetris Delos; Todd Baldini; Timothy M Wright; Nancy Pleshko Camacho
Journal:  Calcif Tissue Int       Date:  2007-07-28       Impact factor: 4.333

5.  The PHEX transgene corrects mineralization defects in 9-month-old hypophosphatemic mice.

Authors:  Adele Boskey; Aaron Frank; Yukiji Fujimoto; Lyudmila Spevak; Kostas Verdelis; Bruce Ellis; Nancy Troiano; William Philbrick; Thomas Carpenter
Journal:  Calcif Tissue Int       Date:  2008-12-12       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.